Lisata Therapeutics, Inc. (LSTA)
3.23
+0.03
(+0.94%)
USD |
NASDAQ |
Apr 29, 16:00
3.23
0.00 (0.00%)
After-Hours: 20:00
Lisata Therapeutics Research and Development Expense (TTM) : 7.948M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Penumbra, Inc. | 83.18M |
| Protalix Biotherapeutics, Inc. | 19.57M |
| Agenus, Inc. | 79.34M |
| Curis, Inc. | 28.25M |
| LadRx Corp. | 0.7712M |